EMPACT-MI Results: Empagliflozin After Acute Myocardial Infarction
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
00:00
Introduction
This chapter explores the rationale and outcomes of the IMPACT-MI trial, addressing the high risk of heart failure in post-acute myocardial infarction patients. It discusses the trial design, patient population, primary endpoints, and significant reductions in heart failure events and burden.
Transcript
Play full episode
